Company: RDPTF
Filing Date: 2025-09-18
Form Type: 20-F
Source: 0001213900-25-088699
Chunk: 95

Company: Radiopharm Theranostics Ltd
Filing Date: 2025-09-18
Form: 20-F
Item: Item 5
Chunk 95
---
2024 to A$103,292 in fiscal 2025, due to the recognition of tax payable in Radiopharm (USA) Inc.

Exchange differences on translation of foreign operations

Exchange differences on translation of foreign operations increased from A$202,956 in fiscal 2024 to A$464,034 in fiscal 2025, due to the fluctuation in foreign exchange rates.

Total comprehensive loss

Total comprehensive loss decreased A$9.9 million from A$47.7 million in fiscal 2024 to A$37.9 million in fiscal 2025, principally due to the recognition of A$3.6 million in R&D tax incentives for the fiscal 2024, and a decrease in the loss on movement in contingent consideration of A$4.8 million for the year.

Comparison of Our Results for the Year ended June 30, 2024 with the Year ended June 30, 2023

For results of operations for the years ended June 30, 2024 and 2023, together with the changes in those items in dollars and as a percentage and the related discussions on these results, refer to Results of Operations within “Item 5.A Operating Results” in our Annual Report on Form 20-F/A (Amendment No.2) for the year ended June 30, 2024, filed with the SEC on December 5, 2024.

Off-Balance Sheet Arrangements

During fiscal years 2025 and 2024, we did not have any unconsolidated entities such as structured finance or special purpose entities that can be used to facilitate off-balance sheet arrangements.
Tabular Disclosure of Contractual Obligations 

As of June 30, 2025, our contractual obligations were as set forth below:

                                                                                                 Payments Due by Period                                                                  
                                                                                                           A$                                                                            
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                              Total                     Less than                  Between                      Between                     Between                      More than       
                                                        6 months                   6 – 12 months                1 – 2 years                 2 – 5 years                  5 years         
Trade and other payables           9,340,993                   9,340,993                    -                           -                           -                           -        
Other financial liabilities        32,098,324                  1,363,259                    2,363,259                   8,039,178                   11,585,395                  9,052,414

Contingent liabilities

We had significant